A JAMA viewpoint outlines the tragic story of Shandra Eisenga, a patient who received spine surgery for back pain only to inexplicably contract tuberculosis.

Today, thanks to researchers, medical and public health experts, pharmaceutical companies, engineers and others, we know more and can do more about the coronavirus called SARS-CoV2, and the disease called COVID-19, than ever before.

Measles: 10 things to know about immunization and prevention

Therapies for pain conditions like fibromyalgia provide clues for helping those with long COVID-19

A prospective study published in the journal Lancet Microbe provides more clarity on which patient populations are at higher risk for prolonged infections — and hints that this fear is likely unwarranted.

A Michigan Medicine FAQ about Paxlovid, with new information since its FDA approval in May 2023.

With over 400 stories published on Health Lab in 2023, the following 10 articles were the most read of the year.

A team developed a new approach for combining microbiome data together while overcoming the noise introduced by the different techniques used in each study into a tool they dubbed MaLiAmPi (Maximum Likelihood Amplicon Pipeline).

Focusing on the ‘tripledemic’ of RSV, flu and COVID-19 infections that occurred last year, their results underscore the importance of all types of hospital emergency departments being prepared to care for sick children, especially when health systems become strained.

Winter surges in infectious diseases can ruin holidays, but vaccination against COVID-19, flu, RSV, whooping cough and pneumonia can help.

Michigan Medicine researchers have found that growing bacteria on agar mixed with organs is an efficient and effective way to study infectious pathogens.

Two Michigan Medicine doctors share 8 ways older adults can combat loneliness and social isolation.

Research published from experts at Michigan Medicine, the University of Pittsburgh School of Medicine, and UPMC Children’s Hospital of Pittsburgh shows that children in daycare centers were not significant spreaders of COVID-19

A cost effectiveness analysis of the updated COVID-19 vaccine shows that it will save money in older adults and give good value for other adults.

An expert offers advice for those worried sick about their symptoms.